Caliper Life Sciences Reports First Quarter 20...(venues will be renewed and that our inve...),Health

adjustment as a basis for measuring our ongoing performance, although

there can be no assurance that such contractual arrangements will be

renewed.

3) We exclude amortization of intangible assets from this measure because

we believe intangible asset amortization charges do not represent what

our management and our investors believe are the costs of developing,

producing, supporting and selling our products and the costs to support

our internal operating structure.

4) We exclude restructuring and severance costs from this measure because

they tend to occur as a result of specific events such as acquisitions,

divestitures, repositioning our business or other unusual events that

could make comparisons of long-range trends difficult for management or

investors and could distort performance measures involving our internal

investments and the costs to support our operating structure.

CALIPER LIFE SCIENCES, INC.

SELECTED FINANCIAL INFORMATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

March 31, December 31,

2008 2007

(unaudited) *

Assets

Current assets:

Cash and cash equivalents $13,643 $15,709

Marketable securities 2,587 3,246

Accounts receivable, net 26,682 30,248

Inventories 23,343 19,572

Other current assets 3,834 2,353

Total current assets
'/>"/>